NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/04/2024
Back to search
Official data from USPTO
OLEMA ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
06/04/2024
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
11/18/2020
Registration date
06/04/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/04/2024
Last transaction
06/04/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/08/2024
First use in commerce
01/08/2024
Drawing code
3
Owner type
03
Owner location
San Francisco, CA, US
Examiner
KERTGATE, AMY L
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "Olema" appearing above the stylized word "ONCOLOGY" all appearing to the right of two parallel lines winding within a circle.
Holders and representatives
Holders
Olema Pharmaceuticals, Inc.
Representatives
Sara M. Bauer Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of women's health diseasesdisorders and conditions in the nature of gynecologicalobstetricbreast diseasesdisorders and conditions; pharmaceutical preparations for use in women's healthfor the treatment of cancer; biological preparations for the treatment of cancer; biological preparations for the treatment of women's health diseasesdisorders and conditions in the nature of gynecologicalobstetricbreast diseasesdisorders and conditions
Class 42
Medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of women's health diseasesdisorders and conditions in the nature of gynecologicalobstetricbreast diseasesdisorders and conditions
Class 44
Providing information in the field of cancer preventionscreeningdiagnosis and treatment; providing information in the field of women's health diseasesdisorders and conditions in the nature of gynecologicalobstetricbreast diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/26/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/26/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/28/2024
IUAF
USE AMENDMENT FILED
03/25/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/25/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/25/2024
EX5G
SOU EXTENSION 5 GRANTED
01/24/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/24/2024
EXT5
SOU EXTENSION 5 FILED
01/08/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/30/2023
EX4G
SOU EXTENSION 4 GRANTED
06/28/2023
EXT4
SOU EXTENSION 4 FILED
06/28/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/16/2022
EX3G
SOU EXTENSION 3 GRANTED
12/14/2022
EXT3
SOU EXTENSION 3 FILED
12/14/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/14/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/08/2022
EX2G
SOU EXTENSION 2 GRANTED
06/06/2022
EXT2
SOU EXTENSION 2 FILED
06/06/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/06/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/21/2021
EX1G
SOU EXTENSION 1 GRANTED
12/17/2021
EXT1
SOU EXTENSION 1 FILED
12/17/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/17/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2021
PUBO
PUBLISHED FOR OPPOSITION
06/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/19/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/30/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/30/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/30/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/30/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/30/2021
DOCK
ASSIGNED TO EXAMINER
04/30/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/22/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/21/2021
NWAP
NEW APPLICATION ENTERED
11/21/2020
Continuous trademark protection
Get notified about every new filing that threatens OLEMA ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.